Although the latter study found no difference in AML/MDS overall survival depending on PD-1 expression in blasts [16], another study in AML reported that higher PD-1 expression on leukemic blasts was associated with longer disease-free survival [17]. This evidence concerns the gene PDCD1 and acute myeloid leukemia.